Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.
The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.
Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...
BOLINGBROOK, Ill., Oct. 9, 2024 /PRNewswire/ -- Hyzon (NASDAQ: HYZN) ("Hyzon" or the "Company"), a U.S.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused ...
The Notch signalling pathway is essential for the development and differentiation of various cell types, including immune cells. Notch ligands can promote T cell differentiation, a key step in ...
Solid-state battery developer QuantumScape is approaching the end of 2025 with all of its key goals achieved. The latest development is the installation of key equipment to enable higher-volume QSE-5 ...
GOTTINGEN, GERMANY / ACCESS Newswire / March 16, 2026 / Sartorius launches next-generation platform to boost efficiency in cell therapy productionEveo Cell Therapy Platform enables automated, multi-pa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results